Loading company…
ONWARD develops spinal cord stimulation therapies for people with spinal cord injuries.
Based in Eindhoven, Netherlands, ONWARD develops implantable and external systems that deliver programmed spinal cord stimulation to help restore movement and other functions after spinal cord injury. Formerly known as GTX Medical, the company was led by CEO Dave Marver as of January 2024. In October 2025, it raised EUR 50.85 million in a private placement.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in